Reporting Problems to FDA

Wednesday, February 24, 2010 General News J E 4

SILVER SPRING, Md., Feb. 23 Reports submitted to the Food and Drug Administration (FDA) are an important part of the agency's strategy for identifying risks with products after they've reached the market. These reports help FDA protect the health and safety of all Americans--and can ultimately save lives.

To view the multimedia assets associated with this release, please click

Consumers can make a difference by reporting unexpected side effects, product quality problems, or other problems associated with FDA-regulated products, including food and drugs for people and animals, vaccines and other biologics, medical devices, dietary and nutritional supplements, infant formulas, and cosmetics.

To learn more about reporting problems to FDA, watch the agency's new Consumer Update video at:

To feature this video on your Web site, embed the code from FDA's YouTube channel:

There are a number of ways you can report problems to FDA, depending on the type of problem and product. This Consumer Update article, "Your Guide to Reporting Problems to FDA," includes tips and a chart to help you make your report:

Sign up for e-mail notices of new FDA Consumer Updates at:

View the FDA Consumer Update RSS feed at:

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to:

Related Links:

Reporting Problems to FDA

Your Guide to Reporting Problems to FDA

FDA 101: How to Use the Consumer Complaint System and MedWatch

Media Inquiries: Jason Brodsky 301-827-6251

SOURCE U.S. Food and Drug Administration


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
BioMedix Vascular Solutions, Inc. Partners With Ho...
Ocera Therapeutics Completes Phase 2B Enrollment i...